{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:03:48Z","timestamp":1790345028045,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ero.2026.100228","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:59:13Z","timestamp":1787608753000},"page":"100228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk prediction rules in individuals at risk of rheumatoid arthritis: systematic review and validation using the APIPPRA cohort"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3080-8396","authenticated-orcid":false,"given":"Marianna","family":"Jasenecova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8954-7577","authenticated-orcid":false,"given":"Gabrielle","family":"Harker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-6603","authenticated-orcid":false,"given":"Maryam","family":"Adas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumera","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-0986","authenticated-orcid":false,"given":"Laurence","family":"Duquenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7556-1599","authenticated-orcid":false,"given":"Michelle","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-4755","authenticated-orcid":false,"given":"Elizabeth M A","family":"Hensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7945-6582","authenticated-orcid":false,"given":"Kulveer","family":"Mankia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7552-0463","authenticated-orcid":false,"given":"Katie","family":"Bechman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7385-6166","authenticated-orcid":false,"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-9963","authenticated-orcid":false,"given":"Sam","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6735-5496","authenticated-orcid":false,"given":"Andrew P","family":"Cope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2026.100228_bib0001","series-title":"Rheumatoid Arthritis","year":"2023"},{"key":"10.1016\/j.ero.2026.100228_bib0002","series-title":"Rheumatoid arthritis","author":"Chauhan","year":"2025"},{"key":"10.1016\/j.ero.2026.100228_bib0003","series-title":"Global Burden of Disease Study 2023 (GBD 2023) Results Seattle","year":"2024"},{"issue":"7","key":"10.1016\/j.ero.2026.100228_bib0004","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/acr.23539","article-title":"Increased burden of psychiatric disorders in rheumatoid arthritis","volume":"70","author":"Marrie","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103217","article-title":"Prevention of rheumatoid arthritis: a systematic literature review of preventive strategies in at-risk individuals","volume":"22","author":"Frazzei","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.ero.2026.100228_bib0006","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ero.2026.100228_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001768","article-title":"A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis","volume":"7","author":"Mankia","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2026.100228_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ero.2026.100228_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1221125","article-title":"Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention","volume":"14","author":"Maisha","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ero.2026.100228_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.43218","article-title":"EULAR\/American College of Rheumatology risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia","volume":"78","author":"van Steenbergen","year":"2026","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.ero.2026.100228_bib0011","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1464-5491.2010.03037.x","article-title":"The Leicester risk assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting","volume":"27","author":"Gray","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.ero.2026.100228_bib0012","doi-asserted-by":"crossref","first-page":"b4229","DOI":"10.1136\/bmj.b4229","article-title":"Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores","volume":"339","author":"Hippisley-Cox","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ero.2026.100228_bib0013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"issue":"7611","key":"10.1016\/j.ero.2026.100228_bib0014","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39261.471806.55","article-title":"Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study","volume":"335","author":"Hippisley-Cox","year":"2007","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ero.2026.100228_bib0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/bjc.1987.230","article-title":"Confirmation of a prognostic index in primary breast cancer","volume":"56","author":"Todd","year":"1987","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ero.2026.100228_bib0016","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bjc.1982.62","article-title":"A prognostic index in primary breast cancer","volume":"45","author":"Haybittle","year":"1982","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0017","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: what, why, how, when and where?","volume":"14","author":"Ramspek","year":"2021","journal-title":"Clin Kidney J"},{"issue":"66","key":"10.1016\/j.ero.2026.100228_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22660","article-title":"Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews","volume":"22","author":"Archer","year":"2018","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0019","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41746-023-00832-9","article-title":"Perspectives on validation of clinical predictive algorithms","volume":"6","author":"de Hond","year":"2023","journal-title":"NPJ Digit Med"},{"issue":"4","key":"10.1016\/j.ero.2026.100228_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jamia.2001.0080391","article-title":"Searching for clinical prediction rules in MEDLINE","volume":"8","author":"Ingui","year":"2001","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"10.1016\/j.ero.2026.100228_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032844","article-title":"Search filters for finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews","volume":"7","author":"Geersing","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ero.2026.100228_bib0022","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/art.34445","article-title":"Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunity","volume":"64","author":"Deane","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ero.2026.100228_bib0023","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40265-024-02061-0","article-title":"Prevention of rheumatoid arthritis in at-risk individuals: current status and future prospects","volume":"84","author":"Toyoda","year":"2024","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ero.2026.100228_bib0024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ero.2026.100228_bib0025","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ero.2026.100228_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12874-023-01849-0","article-title":"CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models","volume":"23","author":"Fernandez-Felix","year":"2023","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0029","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13063-019-3403-7","article-title":"Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol","volume":"20","author":"Al-Laith","year":"2019","journal-title":"Trials"},{"issue":"10429","key":"10.1016\/j.ero.2026.100228_bib0030","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(23)02649-1","article-title":"Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial","volume":"403","author":"Cope","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ero.2026.100228_bib0031","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/S2665-9913(25)00371-6","article-title":"Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial","volume":"8","author":"Cope","year":"2026","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"10.1016\/j.ero.2026.100228_bib0032","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/s41588-021-00935-7","article-title":"A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response","volume":"53","author":"Luo","year":"2021","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0272989X9301300107","article-title":"Validation of probabilistic predictions","volume":"13","author":"Miller","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ero.2026.100228_bib0034","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ero.2026.100228_bib0035","unstructured":"Team RC. R: A language and environment for statistical computing (version 4.4.1, 2024-06-14 ucrt). Vienna, Austria: R Foundation for Statistical Computing; 2024. [cited 2026 March 10]. Available from: https:\/\/www.r-project.org\/."},{"issue":"8","key":"10.1016\/j.ero.2026.100228_bib0036","first-page":"6017","article-title":"ExSMART-PreRA: explainable survival and risk assessment using machine learning for time estimation in preclinical rheumatoid arthritis","volume":"29","author":"Salehi","year":"2025","journal-title":"IEEE J"},{"issue":"9","key":"10.1016\/j.ero.2026.100228_bib0037","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/art.43175","article-title":"Serum proteomic signatures before the diagnosis of rheumatoid arthritis: evolving biologic pathways and specific periods of disease development","volume":"77","author":"Rachid Zaim","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0038","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13075-025-03541-8","article-title":"Predicting rheumatoid arthritis progression from seronegative undifferentiated arthritis using machine learning: a deep learning model trained on the KURAMA cohort and externally validated with the ANSWER cohort","volume":"27","author":"Fujii","year":"2025","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.ero.2026.100228_bib0039","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ard.2025.01.042","article-title":"Predictors of arthritis development in individuals at risk of rheumatoid arthritis: a 5-year follow-up study from a large cohort","volume":"84","author":"Frazzei","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ero.2026.100228_bib0040","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/rheumatology\/keae383","article-title":"A predictive model for progression to clinical arthritis in at-risk individuals with arthralgia based on lymphocyte subsets and ACPA","volume":"63","author":"Prajzlerova","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.ero.2026.100228_bib0041","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/03009742.2022.2116806","article-title":"The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development","volume":"52","author":"van Boheemen","year":"2023","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"10.1016\/j.ero.2026.100228_bib0042","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7326\/M23-0272","article-title":"Predicting inflammatory arthritis in at-risk persons: development of scores for risk stratification","volume":"176","author":"Duquenne","year":"2023","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ero.2026.100228_bib0043","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2020-217215","article-title":"Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis","volume":"79","author":"Di Matteo","year":"2020","journal-title":"Annals of the rheumatic diseases"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0044","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13075-019-2002-z","article-title":"A search to the target tissue in which RA-specific inflammation starts: a detailed MRI study to improve identification of RA-specific features in the phase of clinically suspect arthralgia","volume":"21","author":"Matthijssen","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"101648047","key":"10.1016\/j.ero.2026.100228_bib0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fmed.2018.00219","article-title":"Survivin measurement improves clinical prediction of transition from arthralgia to RA biomarkers to improve clinical sensitivity of transition from arthralgia to RA","volume":"5","author":"Erlandsson","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.ero.2026.100228_bib0046","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/amhsr.amhsr_339_15","article-title":"Validation of Leiden score in predicting progression of rheumatoid arthritis in undifferentiated arthritis in indian population","volume":"6","author":"Ghosh","year":"2016","journal-title":"Ann Med Health Sci Res"},{"issue":"9","key":"10.1016\/j.ero.2026.100228_bib0047","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0048","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/annrheumdis-2012-202481","article-title":"Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register\u2013the EPIC-2-NOAR Study)","volume":"73","author":"Lahiri","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ero.2026.100228_bib0049","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ero.2026.100228_bib0050","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/ar4298","article-title":"Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required?","volume":"15","author":"Pratt","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.ero.2026.100228_bib0051","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00296-011-1806-1","article-title":"Predictive factors related to progression toward rheumatoid arthritis in Korean patients with undifferentiated arthritis","volume":"32","author":"Ha","year":"2012","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.ero.2026.100228_bib0052","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.30396","article-title":"Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis","volume":"63","author":"Duer-Jensen","year":"2011","journal-title":"Arthritis and rheumatism"},{"issue":"5","key":"10.1016\/j.ero.2026.100228_bib0053","first-page":"686","article-title":"A clinical prediction rule combining routine assessment and power Doppler ultrasonography for predicting progression to rheumatoid arthritis from early-onset undifferentiated arthritis","volume":"28","author":"Salaffi","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.ero.2026.100228_bib0054","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.27638","article-title":"The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner","volume":"62","author":"Deane","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ero.2026.100228_bib0055","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/art.24711","article-title":"A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies","volume":"61","author":"Tamai","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ero.2026.100228_bib0056","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/art.23681","article-title":"Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making","volume":"58","author":"van der Helm-van Mil","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ero.2026.100228_bib0057","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/art.22380","article-title":"A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions","volume":"56","author":"van der Helm-van Mil","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ero.2026.100228_bib0058","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF01451012","article-title":"Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis","volume":"17","author":"Suenaga","year":"1998","journal-title":"Clinical Rheumatol"},{"issue":"7","key":"10.1016\/j.ero.2026.100228_bib0059","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.clinthera.2019.04.028","article-title":"The Natural history of rheumatoid arthritis","volume":"41","author":"Deane","year":"2019","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.ero.2026.100228_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11926-014-0419-6","article-title":"Preclinical rheumatoid arthritis (autoantibodies): an updated review","volume":"16","author":"Deane","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.ero.2026.100228_bib0061","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00281-017-0620-6","article-title":"Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?","volume":"39","author":"Tracy","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.ero.2026.100228_bib0062","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/S2665-9913(23)00305-3","article-title":"Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study","volume":"6","author":"Garcia-Montoya","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ero.2026.100228_bib0063","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ero.2026.100228_bib0064","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.semarthrit.2013.08.005","article-title":"Diagnostic accuracy of a clinical prediction rule (CPR) for identifying patients with recent-onset undifferentiated arthritis who are at a high risk of developing rheumatoid arthritis: a systematic review and meta-analysis","volume":"43","author":"McNally","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ero.2026.100228_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.ero.2026.100228_bib0066","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1002\/sim.9025","article-title":"Minimum sample size for external validation of a clinical prediction model with a binary outcome","volume":"40","author":"Riley","year":"2021","journal-title":"Stat Med"},{"key":"10.1016\/j.ero.2026.100228_bib0067","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2021.02.011","article-title":"External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb","volume":"135","author":"Snell","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0068","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hpb.2020.07.007","article-title":"Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"23","author":"Buttner","year":"2021","journal-title":"HPB (Oxford)"},{"issue":"5","key":"10.1016\/j.ero.2026.100228_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/sim.70011","article-title":"Instability of the AUROC of clinical prediction models","volume":"44","author":"van Leeuwen","year":"2025","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ero.2026.100228_bib0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12916-023-02779-w","article-title":"There is no such thing as a validated prediction model","volume":"21","author":"Van Calster","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.ero.2026.100228_bib0071","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:30:16Z","timestamp":1790343016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3050708126001278"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.100228","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk prediction rules in individuals at risk of rheumatoid arthritis: systematic review and validation using the APIPPRA cohort","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.100228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100228"}}